Calcite 600mg Tablets 30s is primarily indicated in conditions like Acute hypocalcaemia, Hyperphosphataemiag Hypocalcaemia, Hypoparathyroidism, In hypocalcaemic tetany, Osteoporosis prophylaxis, Osteoporosis, if the actual dietary intake less than the RDA, and can also be given in adjunctive therapy as an alternative drug of choice in Blood Pressure, Cardiopulmonary resuscitation, Hypertension, Premenstrual Syndrome, Severe hyperkalaemia, Severe hypermagnesaemia.
Calcite 600mg Tablets 30s is contraindicated in conditions like Hypercalcaemia, Hypercalciuria, Renal calculi.
The severe or irreversible adverse effects of Calcite 600mg Tablets 30s, which give rise to further complications include Hypotension, Hypotension, Sinus bradycardia. Calcite 600mg Tablets 30s produces potentially life-threatening effects which include Cardiac arrhythmia, Cardiac Arrest, Cardiac arresto which are responsible for the discontinuation of Calcite 600mg Tablets 30s therapy. The symptomatic adverse reactions produced by Calcite 600mg Tablets 30s are more or less tolerable and if they become severe, they can be treated symptomatically, these include Thirst, Headache, Nausea, vomiting, Anorexia, Constipation, Abdominal pain, Dry mouth, Confusion, Syncope, Hypophosphatemia, GI irritation, Hypercalcemia, Dry mouth, Confusion.
Calcite 600mg Tablets 30s salts should be used with caution in patients with impaired renal function, preexisting arrhythmias, dehydration, diarrhoeag malabsorption or diseases associated with elevated vitamin D concentrations such as sarcoidosis. Solution of Calcite 600mg Tablets 30s salts are irritant and care should be taken to prevent extravasation during intravenous injection. Generally Calcite 600mg Tablets 30s salts should be avoided in patients with Calcite 600mg Tablets 30s renal calculi. PlasmaCalcite 600mg Tablets 30s concentrations should be monitored closely in patients with renal insufficiency and during parentral administration and if large doses of vitamin D are used.
There are no reviews yet.